C07K 16/24
Against cytokines, lymphokines or interferons
Official title: against cytokines, lymphokines or interferons
C07K16/24 (Against cytokines, lymphokines or interferons) appears on 4,444 US grants and 7,953 published applications in this corpus.
Search patents in C07K- Granted patents
- 4,444
- Published applications
- 7,953
- Assignees
- 1,952
- Inventors
- 10,724
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 8 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 6 | 0 |
| 1989 | 6 | 0 |
| 1990 | 8 | 0 |
| 1991 | 12 | 0 |
| 1992 | 10 | 0 |
| 1993 | 22 | 0 |
| 1994 | 16 | 0 |
| 1995 | 12 | 0 |
| 1996 | 25 | 0 |
| 1997 | 64 | 0 |
| 1998 | 58 | 0 |
| 1999 | 73 | 0 |
| 2000 | 43 | 0 |
| 2001 | 56 | 26 |
| 2002 | 63 | 103 |
| 2003 | 57 | 204 |
| 2004 | 46 | 149 |
| 2005 | 41 | 171 |
| 2006 | 71 | 196 |
| 2007 | 93 | 188 |
| 2008 | 75 | 196 |
| 2009 | 114 | 265 |
| 2010 | 136 | 293 |
| 2011 | 151 | 294 |
| 2012 | 173 | 306 |
| 2013 | 196 | 305 |
| 2014 | 190 | 417 |
| 2015 | 193 | 391 |
| 2016 | 249 | 387 |
| 2017 | 250 | 369 |
| 2018 | 206 | 379 |
| 2019 | 185 | 416 |
| 2020 | 271 | 463 |
| 2021 | 271 | 485 |
| 2022 | 217 | 415 |
| 2023 | 184 | 435 |
| 2024 | 221 | 422 |
| 2025 | 205 | 364 |
| 2026 | 149 | 314 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antibodies against human TSLP and use thereof6 Oct 2026US 12,753,227 B2Beijing Wisdomab Biotechnology Co., Ltd
- Manufacturing methods for producing anti-IL12/IL23 antibody compositions29 Sep 2026US 12,747,289 B2Janssen Biotech, Inc.
- IL-33 binding antibodies29 Sep 2026US 12,747,290 B2GlaxoSmithKline Intellectual Property Development Limited
- Pharmaceutical products and stable liquid compositions of IL-17 antibodies22 Sep 2026US 12,741,024 B2Novartis AG
- Pharmaceutical composition containing antibody against IL-5 and use thereof22 Sep 2026US 12,742,004 B2Jiangsu Hengrui Medicine Co., Ltd.
- Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof8 Oct 2026US 2026/0306471 A1Insilico Medicine IP Limited
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Method of treating crohn's disease with a combination of antibodies to il-23 and tnf alpha8 Oct 2026US 2026/0308243 A1Janssen Biotech, Inc.
- Treatment of autoimmune diseases8 Oct 2026US 2026/0308244 A1UCB Developed Brands SRL
- A high-concentration monoclonal antibody formulation and uses thereof8 Oct 2026US 2026/0308245 A1Jiangsu Biojetay Biotechnology Co., Ltd.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996